Connect with us

News

“I was sceptical about cannabis, now I help others overcome stigma”

Published

on

Janice Newell-Bissex - holistic cannabis practitioner and author

Holistic cannabis practitioner, Janice Newell-Bissex was sceptical when her dad was prescribed medical cannabis. Now she’s helping others access the ‘life-changing’ treatment and teaching the next generation of health professionals about its potential.

Like many people, Janice’s first experience with cannabis was at university. A month before her graduation, she decided she had to try it; she might never get another chance, she thought.

She soon realised that it wasn’t for her and didn’t cross paths with cannabis again until 2016, several decades later, when her dad fell ill.

Complications with surgery meant a five-day hospital stay turned into five-months. He suffered from a debilitating condition that caused blood clots throughout his body and eventually led to multiple spinal fractures and severe pain.

Although he never complained, Janice’s dad continued to suffer for a number of years with pain along with the side effects of traditional pain medication.

“This man who went into hospital as a very vibrant 82-year-old, came out disabled,” Janice recalls.

“He was just zombified by taking all these pain meds.”

After a four-day hospital visit resulting from one of these side effects, Janice knew she had to find an alternative.

At the time, medical cannabis had just been legalised in her home state of Massachusetts. Sceptical about whether the plant could really help, she hesitantly suggested it to her doctor.

To her surprise, he thought it was a great idea and prescribed her dad a high-CBD vape pen.

“He was in excruciating pain,” Janice says.

“We got home and turned the vape pen on and after a couple of puffs he said he was going to take a nap.

“He stood up and he said ‘wow, I’m not in pain’”.

This was the moment that Janice decided instantly to leave her nutrition business, which she had founded and ran for 15 years, and train to become a holistic cannabis practitioner.

Well-respected in her field as a dietician and nutritionist, the 61-year-old believed it was her responsibility to educate her fellow health professionals about the benefits of medicinal cannabis.

“I came from a place where I didn’t understand or even believe that this plant could help,” she says.

“I’ve done a lot of things in my field, I’m old enough that people know me and they respect me. I thought, if not me, who?

“I had a platform. I could help educate other health professionals about this who are sceptical because I understand their scepticism.”

Sadly, Janice’s dad passed away after only four months of taking medical cannabis.

“Now I do this in my dad’s honour,” she continues.

“I think this is his legacy. I can help people avoid the awful pain and side effects and if I can help one person not go through that, then it will be worth it.”

As a holistic cannabis practitioner, Janice consults people with a variety of conditions, from IBS and pain to anxiety and ADHD, helping them find a cannabis-based medicine that works for them.

Although she never claims that medical cannabis will work for everyone, or completely eradicate pain, many of Janice’s clients say the treatment is life-changing.

“I get such lovely notes from clients,” she says.

“I always tell everyone, this is not going to take your pain from ten to a zero. But it can take pain from an eight to a four and make it manageable. And people tell me that’s life-changing.

“It really is the most rewarding work I’ve ever done because people see significant improvements in their quality of life and it’s just astounding.”

As she struggled to find a high-quality product that she was happy recommending to her clients, Janice decided to launch a CBD label of her own.

“I never in a million years would have thought I would sell products under my own label.

“But as it turns out, it’s a good thing, because now I have control over the quality of medicine that my clients take. If it doesn’t work, I know that it’s not because it’s a poor quality product.”

Janice is now turning her attention to the next generation of cannabis health practitioners, teaching at John Patrick University in Indiana on its online master’s programme in integrative and functional medicine.

Two months ago, the university received approval to include a specific module on cannabinoid medical sciences for which Janice now serves as co-programme director.

“The course is geared to the working professional, so we have doctors, nurses, dieticians and social workers,” she explains.

“What I’m really passionate about is educating the next group of health care providers, because so many doctors don’t understand the power of this plant.

“It’s through no fault of their own; they weren’t trained in it.”

Janice hopes further education and research will help tackle the stigma surrounding cannabis and lessen the healthcare system’s reliance on pharmaceutical drugs.

“A lot of people are afraid,” she adds.

“There is still a lot of stigma and that’s part of my role, as I see it, to help people get over that stigma.”

Janice is also author of  Simple Guide to CBD 

Find out more at www.jannabiswellness.com 

Advocacy

Fair Trials and Last Prisoner Project seek to launch global cannabis justice project

Fair Trials’ Global CEO Norman L. Reimer to discuss the project at Cannabis Europa Conference in London on June 29.

Published

on

fair trials cannabis justice

A new initiative from Fair Trials and the Last Prisoner Project aims to redress the harm caused by cannabis prohibition and to secure relief for those in prison for cannabis-related convictions.

The criminal justice reform NGO, Fair Trials hopes that the industry will support its work in countries across the globe where cannabis laws are being liberalised. Through collaboration with local partners in appropriate jurisdictions, the Fair Trials project will identify people in need of legal assistance, and recruit, train and match volunteer lawyers to take on their cases.

Fair Trials has enlisted the help of the Last Prisoner Project, a coalition of cannabis industry leaders, executives and artists dedicated to bringing restorative justice to the cannabis sector.

More and more jurisdictions are allowing adults to use and distribute medical and recreational cannabis. But after decades of prohibition, countless people remain behind bars or continue to suffer the collateral consequences of a cannabis conviction.

US research programme studies cannabinoids in ovarian cancer

“The injustice of cannabis prohibition has resulted in millions of people worldwide serving time in prison or being saddled with a cannabis conviction, which brings with it a lifetime of harmful consequences, ranging from education and employment opportunities to immigration status and parental rights,” said Fair Trials Global CEO, Norman L Reimer.

“Of course, these harmful effects of prohibition not only impact the individuals charged, but also their families and communities. And those effects have been borne disproportionately by minorities, communities of colour, and the socio-economically disadvantaged. Legalising cannabis alone does not equal justice. Together, we must address the ongoing harms of past prohibition and leave no cannabis prisoner behind.”

The project will be modelled on the US Cannabis Justice Initiative, a collaborative effort between the cannabis industry and volunteer lawyers in the United States. When Norman Reimer was the Executive Director of the National Association of Criminal Defense Lawyers (NACDL), he partnered with the Last Prisoner Project to establish the initiative.

“Key to the success of the initiative has been generous donations from legal cannabis companies and consumers nationwide,” said Last Prisoner Project Co-Founder Steve DeAngelo. “Fair Trials, with its global reach as the world’s criminal justice watchdog, is uniquely positioned to build and house the infrastructure that’s going to be needed.”

Tomorrow (29 June), Norman Reimer will address the Cannabis Europa Conference discussing the project. Mr Reimer will be part of a panel entitled ‘Leave No Cannabis Prisoner Behind,’ and will be joined on that panel by Mary Bailey, Managing Director at the Last Prisoner Project; Dr. Laura Garius, Policy Lead at Release; and Denzel Uba, an individual impacted by criminal cannabis prohibition.

Continue Reading

Advocacy

TOWIE star Amy Childs launches CBD range in honour of Jorja Foundation

The product range sees a portion of the proceeds going to the Jorja Foundation.

Published

on

Amy Childs at the launch of her new CBD range, Jorja Botanicals

TOWIE star Amy Childs launched her new CBD range this week, with a star-studded event that shone a spotlight on the story of six-year-old Jorja Emerson.

Amy Childs was joined by former Love Islanders, Amy Hart and Cara Delahoyde-Massey, alongside her  co-stars, Frankie Essex, Tom Skinner, Carina Lepore, Saffron Lempriere and Mark Ferris, for a heart-warming event celebrating the launch of her new CBD Infused beauty range, Jorja Botanicals.

The signature collection sees a portion of the proceeds going to the Jorja Foundation, which was set up in honour of six-year-old medical cannabis patient, Jorja Emerson.

The event saw The Only Way Is Essex star Frankie Essex, break down in tears as she heard Jorja’s story. Frankie, who gave birth to twins four weeks ago, wiped her eyes when Robin Emerson, Jorja’s father, showed videos of the life-threatening seizures his daughter was suffering before they discovered medical cannabis

Love Island star, Amy Hart has since taken to Instagram to spread the word about the latest political campaign that sees Childs and Emerson petitioning to make medical cannabis more widely available on the NHS

The Jorja Botanicals range was inspired by Jorja, who was diagnosed with a rare chromosome abnormality called 1q43q44 deletion, which has a side effect of life-threatening seizures. Her illness resulted in her being admitted to intensive care on two separate occasions, where Robin was told that she may not make it.

jorja botanicals

TOWIE stars joined Amy Childs for the launch of her new CBD range

To save his daughter’s life, Emerson knew that he had to dig deep and find a treatment that would not only help Jorja but ultimately go on to help others.

At the time it was still illegal to prescribe cannabis in the UK. Emerson joined the campaign to see medical cannabis legalised in the UK in November 2018, and Jorja’s was among the first children to be legally prescribed medicinal cannabis.

In 2021 he went on to create the Jorja Foundation – a charity set up to help other families and children going through the same battles that Robin had to face.

The Jorja Foundation’s core principles are to fund special needs equipment that is not funded through the health system, fund family counselling, private appointments and tests when a second opinion is needed, as well s cannabis-based treatment for children in the UK and to continue to campaign and educate for wider NHS access in the UK for cannabis-based medications.  

Childs commented: “When I saw Robin & Jorja’s story on social media it broke my heart.

As a mum, I couldn’t imagine the pain of being told to take my child home to say goodbye to them. I love that Robin has fought for Jorja & is now helping other families with the Jorja Foundation. 

“I’m so happy that I can help the foundation by being the Creative Director of Jorja Botanicals. We have created some beautiful products for the whole family to enjoy. We will be donating a percentage of the proceeds to the foundation so that we can help as many families as possible. ”

 Emerson added: “ This is the fruition of a lot of hard work over many months and I am extremely proud to launch what is the first family brand in this category. In the coming weeks, we will also be launching a ‘parent’ focused cosmetic range in partnership with our creative director Amy Childs and our premium line of tincture oils.”

 

Home » News » “I was sceptical about cannabis, now I help others overcome stigma”

Continue Reading

News

South Africa launches first trial of cannabis for chronic pain

The study will test whether cannabis can replace opioids in the management of chronic pain.

Published

on

south africa cannabis trial

South Africa’s first cannabis trial has launched after initial results “show promise” for the treatment as a replacement for opioids.

The Pharma Ethics Observational Study is led by Biodata, a subsidiary of Labat Africa, and will test whether cannabis can replace opioids in the management of chronic pain.

The study will involve 1,000 participants who have been taking opioids for pain management for at least three months and are prepared to switch to cannabis as an alternative.

Biodata is the brainchild of Dr Shiksha Gallow, a cannabis clinician and the principal investigator in the trial which took over 18 months to get official clearance.

US research programme studies cannabinoids in ovarian cancer

Dr Gallow said the trial is set to be ground-breaking as South Africa’s first real-world study of medical cannabis. Researchers predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes.

Dr Gallow told Cannabiz Africa: “We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live Study. It has been fairly slow. However, more options have been introduced, as suggested by the patients in the pilot study.

“The pilot results of the study were very promising, as it showed 98 per cent of the patients have some sort of pain relief from the cannabis.

“We were able to wean these patients off their opioid treatment. In the pilot group of patients below the age of 55, it was shown this group preferred to smoke cannabis and patients older than 55 years preferred oil. The patients who smoked the cannabis had relief almost immediately, while the oil took some time to alleviate their pain.”

“Once we reach the sample size required and all of the relevant data has been collated, the results of the study will be published. We have currently renewed this study for another year, due to the initial slow uptake of research participants.”

Patients can apply to be research participants through the Biodata website.

Labat is expanding its footprint over the next few months with the introduction of CannAfrica kiosks in major shopping malls.

The company believes these will be the “ideal locations for physical sign-up points for the study”.

Labat said the kiosks will also serve as Biodata dispensaries and is engaging with a number of vape stores to do the same, although these would have to be subject to South African Health Products Regulatory Authority’s pharma-ethics requirements.

Home » News » “I was sceptical about cannabis, now I help others overcome stigma”

Continue Reading

Trending